A Phase Ii Single-Arm Open-Labeled Study Evaluating Combination Of Quizartinib And Omacetaxine Mepesuccinate (Quizom) In Newly Diagnosed Or Relapsed/Refractory Aml Carrying Flt3-Itd

BLOOD(2019)

引用 4|浏览52
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要